Sonavex: Funding, Investors & Team (Sep 2026)
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on Empowered Patient Care. The company has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs. EchoMark is a bioresorbable and highly echogenic (visible under ultrasound) implant used to mark at-risk blood vessels such that the site can be easily assessed for future complications. EchoSure is a deep-learning enabled 3D automated ultrasound device designed to be used by healthcare providers without ultrasound training to assess blood flow and morphology of vessels marked by the implanted EchoMark device. For more information, please visit http://www.sonavex.com
Sonavex has raised $18.1M across 2 funding rounds on record, the most recent an undisclosed round of $3.1M announced in Jul 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sonavex Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Sonavex Funding Rounds
Sonavex raised $15.0M in a Series A announced in Oct 2024.
1.8 years later, an undisclosed round of $3.1M was announced in Jul 2026.
Sonavex Investors
21 investors are recorded in total; the 5 named above are those the record identifies.
Sonavex Founders and Leadership Team
Contact details for the Sonavex team: 2 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Sonavex Funding Compared to Other Biotechnology Startups
Sonavex's latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sonavex in Biotechnology and Baltimore
Companies Similar to Sonavex
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Sonavex Funding FAQs
What does Sonavex do?
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on Empowered Patient Care. The company has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs. EchoMark is a bioresorbable and highly echogenic (visible under ultrasound) implant used to mark at-risk blood vessels such that the site can be easily assessed for future complications. EchoSure is a deep-learning enabled 3D automated ultrasound device designed to be used by healthcare providers without ultrasound training to assess blood flow and morphology of vessels marked by the implanted EchoMark device. For more information, please visit http://www.sonavex.com
How much funding has Sonavex raised?
Sonavex has raised $18.1M across 2 rounds on record. The most recent is an undisclosed round of $3.1M announced in Jul 2026.
When did Sonavex last raise funding?
Sonavex's most recent funding round on record is an undisclosed round of $3.1M, announced in Jul 2026.
Who has invested in Sonavex?
Investors on record for Sonavex include TEDCO, Gaingels, Fusion Fund, National Science Foundation, Partners Capital. FundedIQ records 21 investors in total.
Who founded Sonavex?
FundedIQ lists Jerry Prince (Founder) at Sonavex.
Who is the CEO of Sonavex?
David Narrow is listed as CEO at Sonavex.
Where is Sonavex headquartered?
Sonavex is based in Baltimore, Maryland, United States.
How many employees does Sonavex have?
Sonavex is in the 1-10 employee band.
When was Sonavex founded?
Sonavex was founded in 2013.
How does Sonavex's funding compare to other Biotechnology startups?
Sonavex's latest round of $3.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Sonavex Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sonavex is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.